Calcific aortic valve disease: mechanisms, prevention and treatment

LHM Moncla, M Briend, Y Bossé… - Nature Reviews Cardiology, 2023 - nature.com
Calcific aortic valve disease (CAVD) is the most common disorder affecting heart valves and
is characterized by thickening, fibrosis and mineralization of the aortic valve leaflets …

Calcific aortic valve disease: a developmental biology perspective

P Dutta, J Lincoln - Current Cardiology Reports, 2018 - Springer
Abstract Purpose of Review This review aims to highlight the past and more current literature
related to the multifaceted pathogenic programs that contribute to calcific aortic valve …

Calcific aortic valve disease-natural history and future therapeutic strategies

B Alushi, L Curini, MR Christopher… - Frontiers in …, 2020 - frontiersin.org
Calcific aortic valve disease (CAVD) is the most frequent heart valve disorder. It is
characterized by an active remodeling process accompanied with valve mineralization, that …

Development of calcific aortic valve disease: do we know enough for new clinical trials?

AE Kostyunin, AE Yuzhalin, EA Ovcharenko… - Journal of molecular and …, 2019 - Elsevier
Calcific aortic valve disease (CAVD), previously thought to represent a passive
degeneration of the valvular extracellular matrix (VECM), is now regarded as an intricate …

Calcific aortic valve disease: from molecular and cellular mechanisms to medical therapy

S Kraler, MC Blaser, E Aikawa, GG Camici… - European heart …, 2022 - academic.oup.com
Calcific aortic valve disease (CAVD) is a highly prevalent condition that comprises a disease
continuum, ranging from microscopic changes to profound fibro-calcific leaflet remodelling …

Aortic valve stenosis: from basic mechanisms to novel therapeutic targets

PR Goody, MR Hosen, D Christmann… - … , and vascular biology, 2020 - Am Heart Assoc
Aortic valve stenosis is the most prevalent heart valve disease worldwide. Although
interventional treatment options have rapidly improved in recent years, symptomatic aortic …

Molecular and cellular aspects of calcific aortic valve disease

DA Towler - Circulation research, 2013 - Am Heart Assoc
Calcific aortic valve disease (CAVD) increasingly afflicts our aging population. One third of
our elderly have echocardiographic or radiological evidence of calcific aortic valve sclerosis …

[HTML][HTML] Calcific aortic valve disease: molecular mechanisms and therapeutic approaches

DA Lerman, S Prasad, N Alotti - European Cardiology Review, 2015 - ncbi.nlm.nih.gov
Calcification occurs in atherosclerotic vascular lesions and in the aortic valve. Calcific aortic
valve disease (CAVD) is a slow, progressive disorder that ranges from mild valve thickening …

Potential drug targets for calcific aortic valve disease

JD Hutcheson, E Aikawa, WD Merryman - Nature Reviews Cardiology, 2014 - nature.com
Calcific aortic valve disease (CAVD) is a major contributor to cardiovascular morbidity and
mortality and, given its association with age, the prevalence of CAVD is expected to continue …

Inflammatory and biomechanical drivers of endothelial-interstitial interactions in calcific aortic valve disease

K Driscoll, AD Cruz, JT Butcher - Circulation research, 2021 - Am Heart Assoc
Calcific aortic valve disease is dramatically increasing in global burden, yet no therapy
exists outside of prosthetic replacement. The increasing proportion of younger and more …